Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma

K. Ohta, M. Adachi (Tokyo, Japan)

Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Session: Recent advances in the treatment and pathogenesis of asthma
Session type: Thematic Poster Session
Number: 3626
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Ohta, M. Adachi (Tokyo, Japan). Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma. Eur Respir J 2008; 32: Suppl. 52, 3626

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Mark James - 06.10.2008 16:22
Flexible Dosing in Japan
Thank you for presenting this trial. You have used a fixed-dose regimen for the study which is in line with the requirements of your drug regulatory authorities. What is your opinion about the usefulness of the flexible, or so called "SMART" dosing with this combination? Is this applicable in Japanese clinical practice? Thank you.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy and safety of fluticasone/formoterol compared to fluticasone alone in patients with asthma
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008

Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 458s
Year: 2007

Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Effectiveness and safety of fluticasone propionate/salmeterol 250/50mcg administered once daily to patients with persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 309s
Year: 2004

Safety and tolerability of high-dose formoterol via aerolizer and salbutamol via MDI in patients with mild-to-moderate COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 285s
Year: 2003

Long-term safety of inhaled formoterol in adult asthma patients
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Efficacy and safety of therapeutic and supratherapeutic doses of indacaterol compared to salmeterol and salbutamol, in mild-to-moderate asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 207s
Year: 2006

Efficacy of inhaled ciclesonide compared with oral prednisolone in the treatment of asthma exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006

Efficacy and safety of combined mometasone furoate/formoterol 100/10μg twice daily in subjects with asthma inadequately controlled on low-dose inhaled corticosteroids
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010


Efficacy and safety of ciclesonide compared with fluticasone propionate in patients with moderate to severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 206s
Year: 2006

Efficacy and safety of transdermal tulobuterol (LABA) on asthma patients
Source: Annual Congress 2007 - New treatments for asthma
Year: 2007


Efficacy of high-dose inhaled fluticasone propionate in Indian patients having moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Efficacy of long-term formoterol therapy vs as-needed salbutamol use in patients with moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 426s
Year: 2001

Cost-effectiveness of budesonide and formoterol in a single inhaler compared to fluticasone in the treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 157s
Year: 2001

Pharmacokinetics of tiotropium administered by Respimat in adolescent asthma patients
Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues
Year: 2017


Safety of as-needed formoterol in asthma patients on different maintenance long-acting ß2-agonists
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Safety profile of ciclesonide as compared with fluticasone propionate in the treatment of children and adolescents with asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 346s
Year: 2004

A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD
Source: Eur Respir J 2014; 43: 763-772
Year: 2014



Efficacy and safety profile of doxofylline compared to theophylline in asthma: a meta-analysis
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019